<DOC>
	<DOCNO>NCT00481533</DOCNO>
	<brief_summary>Despite marked improvement clinical management , early postpartum hemorrhage ( PPH ) remain significant contributor maternal morbidity mortality develop country hospital equip modern medicine offer . This complication amongst challenge clinician face obstetric patient . Prevention , early recognition prompt appropriate intervention key minimize impact PPH woman ’ health . Patients undergoing Cesarean section follow failure progress labor great risk PPH theoretically benefit additional uterotonic agent . This study conduct define whether addition ergonovine maleate oxytocin , administer prophylactic way , reduces blood loss Cesarean section failure progress labor .</brief_summary>
	<brief_title>Ergot Oxytocin During Cesarean Delivery Following Failure Progress Labour</brief_title>
	<detailed_description>Despite marked improvement management , early postpartum hemorrhage ( PPH ) remain significant contributor maternal morbidity mortality develop country hospital equip modern medicine offer . This complication amongst challenge clinician face Obstetrics . Prevention , early recognition prompt appropriate intervention key minimize impact PPH woman ’ health . Prophylactic oxytocin , commonly administer fetal placental delivery , show reduce incidence PPH . The main advantage drug rapid onset action fact cause elevation blood pressure tetanic contraction like ergonovine . The effect oxytocin limit number status oxytocin receptor . Increases dose oxytocin necessarily improve uterine contraction , receptor adequate quantity quality.This cause patient expose oxytocin labor augmentation , oxytocin receptor know reduce number response oxytocin . Therefore , different uterotonic agent , involve different mechanism action use instead . Alternative drug include ergot derivative prostaglandin ( carboprost misoprostol ) . Although protection PPH ergot derivative prostaglandin appear similar , prostaglandin associate side effect . Patients undergoing Cesarean section follow failure progress labor great risk PPH theoretically benefit additional uterotonic agent . This study conduct define whether addition ergonovine maleate oxytocin , administer prophylactic way , reduces blood loss Cesarean section failure progress labor .</detailed_description>
	<mesh_term>Blood Loss , Surgical</mesh_term>
	<mesh_term>Dystocia</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Ergonovine</mesh_term>
	<criteria>Cesarean section secondary failure progress labour First stage labour Received oxytocin least 4 hour Require General Anesthesia Cardiac Disease Hypertension Predisposition uterine atony postpartum hemorrhage</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Cesarean Delivery</keyword>
	<keyword>Uterine Contractility</keyword>
</DOC>